Enanta Pharmaceuticals
ENTA
ENTA
171 hedge funds and large institutions have $1.14B invested in Enanta Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 62 increasing their positions, 63 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% less repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 63
3% less funds holding
Funds holding: 176 → 171 (-5)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
171
Holding in Top 10
2
Calls
$7.97M
Puts
$5.03M
Top Buyers
| 1 | +$29.4M | |
| 2 | +$13.1M | |
| 3 | +$8.3M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$7.5M |
| 5 |
Morgan Stanley
New York
|
+$4.32M |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$11.5M | |
| 3 | -$9.82M | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$7.8M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$5.69M |